SEATTLE, WA, Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5 million in Series B funding. Read More
NEW YORK, NY, Ro, the direct-to-patient healthcare company, today announced it has raised an additional $150 million exclusively from existing investors. Read More
SANTA BARBARA, CA, KOS, the plant-based powerhouse and functional nutrition brand, announces today the closing of its milestone $12 million Series A investment. Read More